Ananda Pharma (STU:1FX) EV-to-FCF: (As of Jul. 22, 2026)

Ananda Pharma  (STU:1FX) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Ananda Pharma's PE Ratio (TTM) for today is calculated as:

Ananda Pharma's share price for today is €0.0005.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ananda Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jul. 2025 was €-0.002.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Ananda Pharma EV-to-FCF Related Terms

The historical data trend for Ananda Pharma's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ananda Pharma EV-to-FCF Chart

Ananda Pharma Semi-Annual Data
	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23	Jan24	Jul24	Jan25	Jul25
EV-to-FCF	Get a 7-Day Free Trial										0.00	-15.71	0.00	-22.89	0.00

STU:1FX vs ZTS, UTHR, VTRS: EV-to-FCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ananda Pharma's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ananda Pharma EV-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ananda Pharma's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Ananda Pharma's EV-to-FCF falls into.

Ananda Pharma EV-to-FCF Calculation

Ananda Pharma's EV-to-FCF for today is calculated as:

Ananda Pharma's current Enterprise Value is €2.36 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ananda Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Jul. 2025 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ananda Pharma Business Description